- Home
- HYFM vs AIFF Comparison
HYFM vs AIFF Comparison
Compare HYFM & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYFM
- AIFF
- Stock Information
- Founded
- HYFM 1977
- AIFF 2006
- Country
- HYFM United States
- AIFF United States
- Employees
- HYFM N/A
- AIFF N/A
- Industry
- HYFM Industrial Machinery/Components
- AIFF
- Sector
- HYFM Industrials
- AIFF
- Exchange
- HYFM Nasdaq
- AIFF NYSE
- Market Cap
- HYFM 17.1M
- AIFF 37.9M
- IPO Year
- HYFM 2020
- AIFF N/A
- Fundamental
- Price
- HYFM $3.63
- AIFF $3.08
- Analyst Decision
- HYFM Hold
- AIFF
- Analyst Count
- HYFM 2
- AIFF 0
- Target Price
- HYFM $7.00
- AIFF N/A
- AVG Volume (30 Days)
- HYFM 9.4K
- AIFF 1.6M
- Earning Date
- HYFM 08-07-2025
- AIFF 08-18-2025
- Dividend Yield
- HYFM N/A
- AIFF N/A
- EPS Growth
- HYFM N/A
- AIFF N/A
- EPS
- HYFM N/A
- AIFF N/A
- Revenue
- HYFM $176,650,000.00
- AIFF $139,000.00
- Revenue This Year
- HYFM $5.45
- AIFF N/A
- Revenue Next Year
- HYFM $5.33
- AIFF N/A
- P/E Ratio
- HYFM N/A
- AIFF N/A
- Revenue Growth
- HYFM N/A
- AIFF N/A
- 52 Week Low
- HYFM $1.50
- AIFF $1.86
- 52 Week High
- HYFM $8.55
- AIFF $17.20
- Technical
- Relative Strength Index (RSI)
- HYFM 53.66
- AIFF 48.99
- Support Level
- HYFM $3.52
- AIFF $2.70
- Resistance Level
- HYFM $3.93
- AIFF $3.09
- Average True Range (ATR)
- HYFM 0.32
- AIFF 0.26
- MACD
- HYFM -0.02
- AIFF 0.02
- Stochastic Oscillator
- HYFM 65.82
- AIFF 30.84
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.